7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Dental Pulp Exposure D003789 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Hemarthrosis D006395 1 associated lipids
Cherubism D002636 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Emphysema D004646 1 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Ankylosis D000844 1 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Guzel S et al. Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. 2013 Diab Vasc Dis Res pmid:22496403
Xi L et al. OPG/RANK/RANKL axis in atrial fibrillation. 2013 Cardiology pmid:23752030
Ostrowska Z et al. Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. 2013 Postepy Hig Med Dosw (Online) pmid:23752595
Uehara H et al. Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. 2013 Int. J. Oncol. pmid:23708710
Albu A et al. Bone metabolism regulators and arterial stiffness in postmenopausal women. 2013 Maturitas pmid:23916080
Bauer S et al. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. 2013 Epilepsy Res. pmid:23916144
Nile CJ et al. Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. 2013 J. Clin. Periodontol. pmid:23919740
O'Sullivan EP et al. A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. 2013 Metab. Clin. Exp. pmid:22841521
Wang J et al. Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. 2013 Med. Hypotheses pmid:24074896
Kuo PL et al. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. 2013 Biochim. Biophys. Acta pmid:23458685
Sato K et al. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. 2013 Am. J. Pathol. pmid:23499553
Zappitelli T et al. The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. 2013 J. Bone Miner. Res. pmid:23606335
Kao SY et al. Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. 2013 Neurobiol. Dis. pmid:23607938
Eren MA et al. Association of parity with osteoprotegerin levels and atherosclerosis. 2013 Arch. Gynecol. Obstet. pmid:23287888
Kim SJ et al. Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. 2013 Arch. Oral Biol. pmid:23219295
Kanzaki H et al. Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. 2013 Exp. Mol. Pathol. pmid:23219833
Wang H et al. Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. 2013 Gene Ther. pmid:22318091
Zhang Q et al. Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. 2013 ScientificWorldJournal pmid:24222748
Zhang F et al. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. 2013 Med. Oncol. pmid:23335067
Su SJ et al. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. 2013 Int J Food Sci Nutr pmid:23301724
Pathan E et al. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. 2013 Ann. Rheum. Dis. pmid:22984171
Romagnoli C et al. Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. 2013 FEBS J. pmid:23176170
Kadkhodazadeh M et al. Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. 2013 Arch. Oral Biol. pmid:23177932
Barbieri G et al. Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. 2013 Angle Orthod pmid:22716279
Mercatali L et al. RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. 2013 Int J Mol Sci pmid:23702841
Braun T et al. Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. 2013 J. Bone Miner. Res. pmid:23169443
Rivadeneira F Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. 2013 Endocrine pmid:23001603
Giganti MG et al. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. 2012 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:23241117
Heitzer E et al. IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. 2012 Nov-Dec Pain Physician pmid:23159968
Nuño-Arana I et al. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. 2012 Jul-Aug Am. J. Hum. Biol. pmid:22434650
Varsavsky M et al. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. 2012 Jul-Aug J. Androl. pmid:21903971
Dalezis P et al. Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. 2012 Jan-Feb In Vivo pmid:22210719
Ambroszkiewicz J et al. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. 2012 Apr-Jun Med Wieku Rozwoj pmid:22971655
Tobón-Arroyave SI et al. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. 2012 J. Clin. Periodontol. pmid:23039038
Udomsuk L et al. Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice. 2012 Fitoterapia pmid:23041523
Yang Y et al. [Association between osteoprotegerin gene polymorphisms and severe pre-eclampsia in Chinese women]. 2012 Zhonghua Fu Chan Ke Za Zhi pmid:22455689
Xiang G et al. Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto's thyroiditis with euthyroidism. 2012 Exp. Clin. Endocrinol. Diabetes pmid:23070830
Lekva T et al. TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover. 2012 Eur. J. Endocrinol. pmid:22450549
Wang D et al. Accelerated calvarial healing in mice lacking Toll-like receptor 4. 2012 PLoS ONE pmid:23071670
Ming LG et al. [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. 2012 Yao Xue Xue Bao pmid:22512027
Chaves MD et al. Bovine hydroxyapatite (Bio-Oss(®)) induces osteocalcin, RANK-L and osteoprotegerin expression in sinus lift of rabbits. 2012 J Craniomaxillofac Surg pmid:22513050
Koole D et al. Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22516062
Rattazzi M et al. Osteoprotegerin levels are increased in patients with venous thromboembolic disease. 2012 J. Thromb. Haemost. pmid:22486966
Chen X et al. Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. 2012 Biol Trace Elem Res pmid:22076734
Robinson DE et al. Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. 2012 Biomaterials pmid:22079008
Aliprantis AO et al. Transient muscle paralysis degrades bone via rapid osteoclastogenesis. 2012 FASEB J. pmid:22125315
Al-Sabbagh M et al. Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. 2012 J. Periodont. Res. pmid:22126530
Talib A et al. The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients. 2012 Hypertens. Res. pmid:22129515
Kim S et al. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis. 2012 Diagn. Microbiol. Infect. Dis. pmid:22647538
Jørgensen L et al. Osteoprotegerin is associated with hip fracture incidence: the Tromso Study. 2012 Int J Epidemiol pmid:22538253
Motovska Z et al. Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. 2012 Int. J. Cardiol. pmid:22592030
Güncü GN et al. Effect of inflammation on cytokine levels and bone remodelling markers in peri-implant sulcus fluid: a preliminary report. 2012 Cytokine pmid:22592038
Helo S et al. Role of denosumab in prostate cancer. 2012 Prostate Cancer Prostatic Dis. pmid:22370723
Santos VR et al. Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors. 2012 J. Periodont. Res. pmid:21806617
Oelzner P et al. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. 2012 Rheumatol. Int. pmid:20821212
Hwang JJ et al. Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients. 2012 J. Acquir. Immune Defic. Syndr. pmid:22842843
Liang W et al. Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line. 2012 Int. J. Mol. Med. pmid:22842877
Nanda KS et al. Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection. 2012 Cytokine pmid:22863720
Dickerson TJ et al. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. 2012 J. Autoimmun. pmid:22867712
Fossmark R et al. Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice. 2012 J. Cell. Biochem. pmid:21882222
Oka H et al. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. 2012 J. Periodontol. pmid:21910594
Korzon-Burakowska A et al. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. 2012 Diabet. Med. pmid:21913967
Brunetti G et al. Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. 2012 Endocrine pmid:22638612
Lacey DL et al. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. 2012 Nat Rev Drug Discov pmid:22543469
Campia U et al. Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque. 2012 Heart pmid:22543836
Choe WS et al. Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population. 2012 J. Genet. pmid:22546829
Bloch SL et al. The viability of perilabyrinthine osteocytes: a quantitative study using bulk-stained undecalcified human temporal bones. 2012 Anat Rec (Hoboken) pmid:22577084
Canon J et al. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. 2012 Breast Cancer Res. Treat. pmid:22926264
Shuid AN et al. Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. 2012 BMC Complement Altern Med pmid:22967165
Dougall WC Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. 2012 Clin. Cancer Res. pmid:22031096
Sakai N et al. Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice. 2012 Hepatology pmid:22031462
Sanchez C et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression. 2012 Arthritis Rheum. pmid:22034083
Rimondi E et al. Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 2012 Invest New Drugs pmid:21541705
Hulin-Curtis SL et al. Tumour necrosis factor receptor superfamily member 11B polymorphisms and association with knee osteoarthritis in women. 2012 Int. J. Immunogenet. pmid:22296645
Fitzgerald O and Chandran V Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. 2012 J. Rheumatol. pmid:22298273
Silva JA et al. Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis. 2012 Cells Tissues Organs (Print) pmid:22301390
Gradosova I et al. Protective effect of amlodipine on rat bone tissue after orchidectomy. 2012 Pharmacology pmid:22302040
Kennedy OD et al. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. 2012 Bone pmid:22342796
Feng Q et al. [Effect of sonicated extracts of Porphyromonas gingivalis on receptor activator of NF-κB ligand and osteoprotegerin expression in periodontal ligament cells]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23302383
Yilmaz Y and Eren F Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. 2012 Clin. Chim. Acta pmid:22985537
Yan J et al. Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling. 2012 J. Cell. Mol. Med. pmid:22947224
Mlakar SJ et al. Testing GSTP1 genotypes and haplotypes interactions in Slovenian post-/pre-menopausal women: novel involvement of glutathione S-transferases in bone remodeling process. 2012 Maturitas pmid:22221655
Kadkhodazadeh M et al. Analysis of osteoprotegerin (OPG) gene polymorphism in Iranian patients with chronic periodontitis and peri-implantitis. A cross-sectional study. 2012 Eur J Oral Implantol pmid:23304691
Curl L et al. A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. 2012 Aust Orthod J pmid:23304971
Emanuele E et al. Linking atherosclerosis to Alzheimer's disease: focus on biomarkers. 2012 Front Biosci (Elite Ed) pmid:22201906
Karatolios K et al. Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. 2012 Clin. Biochem. pmid:22202560
Jacot W et al. Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. 2012 Breast Cancer Res. Treat. pmid:22562178
Kaneko K et al. Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts. 2012 J. Clin. Endocrinol. Metab. pmid:22791764
Çanga A et al. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. 2012 J Cardiol pmid:22727437
Yoon WJ et al. Sargachromanol G regulates the expression of osteoclastogenic factors in human osteoblast-like MG-63 cells. 2012 Food Chem. Toxicol. pmid:22727857
Miyaji Y et al. Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. 2012 Pharm. Res. pmid:22729371
Khoury N et al. Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab. 2012 J. Clin. Endocrinol. Metab. pmid:22730513
Crotti TN et al. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. 2012 Arthritis Res. Ther. pmid:23146195
Yao Y et al. [The effect of bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22934505
Zhang M et al. [The expression and significance of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in periapical cyst and periapical granuloma]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22934488
Tenta R et al. Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal women. 2012 J. Endocrinol. Invest. pmid:21606670
Liu L et al. [Effect of gradually induced disordered occlusion on the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in mandibular condylar cartilage of rats]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22594224
Zhou W et al. [Expression of receptor activator nuclear factor kappa B ligand and osteoprotegerin in peri-implant soft tissue and bone tissue]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22389960
Histing T et al. Increased osteoblast and osteoclast activity in female senescence-accelerated, osteoporotic SAMP6 mice during fracture healing. 2012 J. Surg. Res. pmid:21571305
Taddei SR et al. Experimental model of tooth movement in mice: a standardized protocol for studying bone remodeling under compression and tensile strains. 2012 J Biomech pmid:23036306

Table of Content